Clinical Trial Update: Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

View source ↗

Summary

Observational real-world study of Inflectra in inflammatory bowel disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• INFLECTRA (infliximab-dyyb)

Snippet

Sponsor: Pfizer | Conditions: Inflammatory Bowel Disease (IBD), Crohn's Disease (CD) | Status: COMPLETED | Results posted: 2021-03-02